Material and Methods: Eighty-three patients who underwent immediate postmastectomy reconstruction with tissue expander between January of 2003 and June of 2012 at the Campus Bio-Medico University Hospital in Rome were retrospectively divided into two groups: Group A (study group) included 30 patients with previous quadrantectomy and radiotherapy who underwent salvage mastectomy after local recurrence and Group B (control group) included 53 patients submitted to primary radical mastectomy. Patients and disease characteristics were analysed and complications were correlated to treatment group.
Results:
The median follow-up time for the whole group was 36 months (range= 12-144 months). Between group A and group B, there were no significant differences in terms of age, body mass index, comorbidities, pathological stage, treatments data (p= NS). In Group A 25/30 patients (83.33%) completed heterologous reconstruction. In 5 patients (16.67%) a conversion to combined or solely autologous reconstruction was needed. In Group B, 52/53 patients (98.11%) completed heterologous reconstruction. In 1 case (1.88%) the expander was removed due to infection and an autologous reconstruction was performed. Revision surgery was needed in 5 patients (9.4%). Autologous salvage reconstruction was more frequent for Group A patients (relative risk 10.4, p=0.02). The overall rate of complications was not different between the two groups (66.6% vs 58.5%; p=0.49) even if major complications (vast necrosis of mastectomy flaps with or without partial implant exposure, with or without implant removal, all III and IV-degree capsular contractures, either requiring or not requiring further surgery) were non significantly higher in the irradiated group (53.3% vs 32.0%; p = 0.07). However, analysing capsular contracture, a significantly higher risk of grade III-IV were recorded in Group A (40% vs 15%; relative risk 3.75, p= 0.02). In Group A the median time from RT to reconstruction was 24 months (range= 9-192 months) and the incidence of major complications was not related to time from RT to reconstruction (p=0.313).
Conclusion:
Heterologus reconstruction after salvage mastectomy in previously irradiated patients, is still possible with satisfactory results. 
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Purpose or Objective: Germline polymorphisms in oxidative stress response genes have been postulated to be involved in the development of late normal tissue complications following radiotherapy. Despite the key role of mitochondria in the production of reactive oxygen species, the contribution of mitochondrial DNA variations to clinical radiosensitivity is still largely unknown. In the present study, we evaluated the association between mitochondrial DNA haplogroups and the risk of radiation-induced subcutaneous fibrosis after postoperative radiotherapy in breast cancer patients.
Material and Methods:
Subcutaneous fibrosis was scored according to the Late Effects of Normal Tissue-Subjective Objective Management Analytical (LENT-SOMA) scale in 286 Italian breast cancer patients who received radiotherapy after breast conserving surgery. Eight mitochondrial DNA (mtDNA) SNPs that define the nine major haplogroups in the European population were determined by PCR-RFLP analysis on genomic DNA extracted from peripheral blood.
Results:
In a Kaplan-Meier analysis evaluated by the log-rank test, carriers of haplogroup H were found at lower risk of grade ³2 subcutaneous fibrosis (P=0.018). In the multivariate Cox regression analysis adjusted for clinical factors (BMI, breast diameter, adjuvant treatment, dose per fraction, radiation type and acute skin toxicity), the haplogroup H emerged as significant protective factor for moderate to severe radiation-induced fibrosis (HR: 0.50, 95% CI 0.27-0.92, P=0.027).
Conclusion:
Our results support a protective role of the mitochondrial haplogroup H in the development of radiationinduced fibrosis in breast cancer patients. Further prospective studies with larger sample size and different populations are nevertheless warranted to corroborate the possible influence of mitochondrial haplogroups on late normal tissue radiosensitivity. 
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